Discern Health and NPC Host Webinar on Strategies to Improve Oncology Measurement

Discern Partner Tom Valuck discusses the White Paper with Kimberly Westrich, NPC VP of Health Services Research

On April 26, Discern Health partnered with the National Pharmaceutical Council (NPC) to host a webinar discussing the findings of the recently published “Improving Oncology Quality Measurement in Accountable Care” white paper.

The webinar, which was moderated by NPC Vice President of Health Services Research Kimberly Westrich and featured Discern Health Partner Tom Valuck, discussed identified measure gaps for 10 high-priority cancers and potential avenues to improve measurement. Three experts in quality measurement and oncology reacted to the findings:

  • Mark McClellan, MD, PhD, director of the Duke-Margolis Center for Health Policy
  • Robert S. Miller, MD, FACP, FASCO, vice president and medical director, CancerLinQ at the American Society of Clinical Oncology (ASCO)
  • Alan Balch, PhD, chief executive officer at the National Patient Advocate Foundation.

Click here to access a recording and slide presentation from the April 26 webinar. To learn more about the project, contact Tom Valuck or David Blaisdell.

Health Affairs Blog Post Highlights Discern’s Work on Serious Illness Care

Discern Partner Tom Valuck, Josh Rising of Pew Charitable Trusts, and Janet Corrigan of the Moore Foundation, recently authored a blog post for Health Affairs titled “Building Additional Serious Illne...
Learn More

About

Capabilities

Contact Us

Insights

Discern Health Presents Potential Measures for Catalyst for Payment Reform’s Scorecard for Payment Reform 2.0

Discern recently worked with Catalyst for Payment Reform (CPR) to develop a list of measures for CPR’s Scorecard for Payment Reform 2.0. CPR has tracked the implementation of payment reform since 2013...
Learn More